Anti-Omalizumab Antibody (7G11), mAb, Mouse
Anti-Omalizumab Antibody (7G11), MAb, Mouse

ELISA binding of Anti-Omalizumab Antibody (7G11), mAb, Mouse (GenScript, A02096-40) with Omalizumab. While the antibody does not recognize the human IgG (data not shown).
Coating antigen: Omalizumab, 1 µg/ml.
Anti-Omalizumab Antibody (7G11), mAb, Mouse (GenScript, A02096-40) dilution start from 1,000 ng/ml.
EC50= 28.48 ng/ml.

Anti-Omalizumab Antibody (7G11), MAb, Mouse

Anti-Omalizumab Antibody (6C9) (GenScript, A02096-40) blocks Omalizumab binding with Human IgE recombinant protein.
Coating antigen: IgE 0.5 µg/ml.
Omalizumab final concentration: 5 ng/ml.
Anti-Omalizumab antibody dilutions start from 10 μg/ml.
IC50= 0.37 µg/ml.

Anti-Omalizumab Antibody (7G11), mAb, Mouse

The product is specific for Omalizumab
A02096
¥25,548.00

Ask us a question
Overview
Specificity The product is specific for Omalizumab
Host Species Mouse
Immunogen Omalizumab
Conjugate Unconjugated

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.005-0.1 µg/ml
Competitive ELISA 10-50 µg/ml

Properties
Form Lyophilized
Storage Buffer This product is lyophilized with PBS, pH 7.2, containing 0.02% sodium azide.
Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
Purification Protein A affinity column
Isotype Mouse IgG1,κ
Clonality Monoclonal
Clone ID 7G11
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Examples
  • Anti-Omalizumab Antibody (7G11), MAb, Mouse
    • Anti-Omalizumab Antibody (7G11), MAb, Mouse

    ELISA binding of Anti-Omalizumab Antibody (7G11), mAb, Mouse (GenScript, A02096-40) with Omalizumab. While the antibody does not recognize the human IgG (data not shown).
    Coating antigen: Omalizumab, 1 µg/ml.
    Anti-Omalizumab Antibody (7G11), mAb, Mouse (GenScript, A02096-40) dilution start from 1,000 ng/ml.
    EC50= 28.48 ng/ml.

  • Anti-Omalizumab Antibody (7G11), MAb, Mouse
    • Anti-Omalizumab Antibody (7G11), MAb, Mouse

    Anti-Omalizumab Antibody (6C9) (GenScript, A02096-40) blocks Omalizumab binding with Human IgE recombinant protein.
    Coating antigen: IgE 0.5 µg/ml.
    Omalizumab final concentration: 5 ng/ml.
    Anti-Omalizumab antibody dilutions start from 10 μg/ml.
    IC50= 0.37 µg/ml.


Background
Target Background Omalizumab with trade name Xolair, is an FDA-approved drug for the treatment of moderate to severe persistent asthma in adults and adolescents (12 years of age and above). It is a recombinant humanized monoclonal antibody. It selectively binds to human immunoglobulin E (IgE). Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. Anti-Omalizumab Antibody (7G11), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Omalizumab.
Synonyms Mouse monoclonal to Omalizumab/Xolair

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.